Pulse Biosciences, Inc. (PLSE) Return on equity 2020–2025
Pulse Biosciences, Inc. (PLSE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-90.2%FY2025 · since FY2020: -217.7% → -90.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -90.2% | -43.6 pp |
| FY2024 | -46.7% | +48.5 pp |
| FY2023 | -95.2% | — |
| FY2021 | -143.5% | +74.2 pp |
| FY2020 | -217.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PLSE financial trends
PLSE RevenuePLSE Net incomePLSE Net marginPLSE Gross profitPLSE Gross marginPLSE Operating incomePLSE Operating marginPLSE Operating cash flowPLSE Free cash flowPLSE Capital expendituresPLSE Stock buybacksPLSE Dividends paidPLSE Total assetsPLSE Total liabilitiesPLSE Shareholders’ equityPLSE overview →